Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Here's Why Investors Should Retain Illumina (ILMN) Stock Now
12:03pm, Tuesday, 31'st May 2022
Investors are optimistic about Illumina's (ILMN) better-than-expected results and revenue contributions from the GRAIL business.
Illumina (ILMN) to Offer Companion Diagnostic for VITRAKVI
03:34pm, Wednesday, 25'th May 2022 Zacks Investment Research
Illumina's (ILMN) first companion diagnostic claim for TSO Comprehensive (EU) will help identify cancer patients with NTRK gene fusions for a genomically matched treatment.
Illumina (ILMN) to Offer Companion Diagnostic for VITRAKVI
01:03pm, Wednesday, 25'th May 2022
Illumina's (ILMN) first companion diagnostic claim for TSO Comprehensive (EU) will help identify cancer patients with NTRK gene fusions for a genomically matched treatment.
EU court to rule July 13 on Illumina challenge of EU review of Grail -sources
12:30pm, Wednesday, 25'th May 2022
A European court will decide on July 13 whether U.S. life sciences company Illumina's $8 billion cash-and-stock takeover of Grail should be scrutinised by EU antitrust regulators, people familiar with
Illumina's (ILMN) Innovations Drive Growth, Cost Woes Linger
01:37pm, Tuesday, 24'th May 2022 Zacks Investment Research
Illumina (ILMN) is working on its goals to strengthen its foothold in the multi-billion gene sequencing market with some highly competitive products in its existing portfolio and pipeline.
Illumina's (ILMN) Innovations Drive Growth, Cost Woes Linger
11:18am, Tuesday, 24'th May 2022
Illumina (ILMN) is working on its goals to strengthen its foothold in the multi-billion gene sequencing market with some highly competitive products in its existing portfolio and pipeline.
3 Biotech Stocks With a Cash Pile Higher Than Their Valuations
12:00pm, Saturday, 21'st May 2022 The Motley Fool
Our roundtable found three biotechs with a nice cash cushion.
This Gene Sequencing Company Is A Better Pick Over Walgreens Stock
06:00am, Friday, 20'th May 2022
We think that Illumina stock (NASDAQ: ILMN) currently is a better pick compared to the Walgreens stock (NYSE: WBA), despite it being the more expensive of the two, trading at 7.8x trailing revenues co
Illumina's (ILMN) GRAIL, Intermountain Healthcare Expand Tie-Up
02:00pm, Wednesday, 18'th May 2022 Zacks Investment Research
Illumina (ILMN) subsidiary GRAIL's MCED blood test will be offered along with existing single cancer screenings to advance cancer care delivery through early detection.
10 Biggest Price Target Changes For Monday
11:53am, Monday, 16'th May 2022 Benzinga
Needham cut the price target on Carvana Co. (NYSE: CVNA) from $121 to $80. Carvana shares rose 11.3% to $42.71 in pre-market trading.
Susquehanna cut Taboola.com Ltd. (NASDAQ: TBLA) price target f
Karen Firestone's top stock picks: Vertex Pharma, Moderna
05:24pm, Friday, 13'th May 2022
Kari Firestone, Aureus Asset Management, joins 'Closing Bell: Overtime' to discuss the biotech bounce and her top stock picks.
These 5-Stock Samplers Have Gotten Whacked. And That's OK
02:32pm, Friday, 13'th May 2022 The Motley Fool
It's all part of investing.
Why Illumina Shares Are Plunging Today?
02:23pm, Monday, 09'th May 2022
A jury in the U.S. District Court for the District of Delaware rendered a verdict that Illumina Inc (NASDAQ: ILMN) willfully infringed the U.S. Patent Nos. 9,222,132 and 10,662,473 owned by Compl
Illumina ordered to pay Chinese company $333 million in gene-sequencing patent case
04:46pm, Friday, 06'th May 2022
A Delaware jury on Friday ordered Illumina Inc to pay more than $333 million to a U.S. unit of Chinese genetic analysis company BGI Genomics after finding that Illumina's DNA-sequencing systems infrin
Illumina (ILMN) Q1 Earnings Beat Estimates, Gross Margin Down
12:02pm, Friday, 06'th May 2022
Illumina (ILMN) ended the first quarter with better-than-expected earnings and revenues on strength in Core Illumina and the GRAIL businesses driving the top line.
